Stock screenerAll disclosures →
EDGAR →
ACRV
Conviction 18HealthcareScan · Mon, Aug 10, 2026ACRV$1.74+0.29%
ResistanceSupportVol 14Insider sellVol MA14 322.38K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price1.74
Change+0.29%
Gap+0.58%
Rel volume1.01×
Avg volume356.71K
Avg $ vol610.14K
SMA 201.67
SMA 501.65
SMA 2001.86
Price vs 50+4.93%
Price vs 200-6.55%
MA stackmixed
50/200 cross—
Supertrenddown · 1.83
RSI (14)55
MACD hist0.01
MACD crossbull · 1d
Stoch %K / %D88 / 83
ADX (14)18
+DI / −DI26 / 20
RSI divergence—
MACD divergence—
ATR %+5.93%
ADR %6.06%
52w high3.01
52w low1.23
From 52w high-42.36%
Above 52w low+41.06%
New 52w highNo
SqueezeOff
Bollinger width36.83%
%B0.60
Donchian pos43.62%
Donchian high2.16
Donchian low1.41
AVWAP (52w high)1.90
vs AVWAP high-8.82%
AVWAP (52w low)1.94
vs AVWAP low-10.50%
OBV trendFlat
Chaikin MF (20)-0.19
Today vs 20d1.01×
Avg vol (14d)322.38K
Avg vol (20d)356.71K
Avg $ vol (20d)610.14K
Market cap74.26M
RS 3m (vs SPY)-20.48%
RS 6m (vs SPY)-5.99%
RS line new highNo
Trend template2/8
Technical rank45.0
1 week+11.22%
1 month-11.48%
3 months-12.37%
6 months+3.89%
1 year+36.61%
YTD-29.47%
P/E-0.95
P/B0.78
P/S—
P/FCF-1.14
EPS-2.02
Div yield—
ROE-81.56%
ROA-72.25%
Debt/Eq—
Current8.98
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth3.29%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value40.2M
Revenue—
Net income-19.04M
Gross profit—
Free cash flow-65.33M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out42.8M
Employees76
ListedTue, Nov 15, 2022
Free float14.39M
Float %45.6%
Short interest1.49M
Days to cover2.3d
Short volume49.8%
Squeeze score39 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction18 / 100
Pattern quality—
Tech rank45.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.93
Support1.41
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ACRV
No recent disclosed trades by Congress in ACRV. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ACRV · 7 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Levy Adam D. Chief Financial Officer · Common Stock · 2026-08-04 | Sell | 1.14K | $2K | 2026-08-04 | 2026-08-06 |
BAUM CHARLES M Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 20.27K | — | 2026-06-17 | 2026-06-22 |
DiRocco Derek Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 20.27K | — | 2026-06-17 | 2026-06-22 |
Magovcevic-Liebisch Ivana Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 20.27K | — | 2026-06-17 | 2026-06-22 |
Palani Santhosh Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 20.27K | — | 2026-06-17 | 2026-06-22 |
Shacham Sharon Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 20.27K | — | 2026-06-17 | 2026-06-22 |
TOMSICEK MICHAEL JOHN Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 20.27K | — | 2026-06-17 | 2026-06-22 |
RA CAPITAL MANAGEMENT, L.P. Director · Stock Option (Right to Buy) · 2026-06-17 | Grant | 20.27K | — | 2026-06-17 | 2026-06-22 |
Blume-Jensen Peter President and CEO · Common Stock · 2026-05-21 | Tax | 13.73K | $25K | 2026-05-21 | 2026-05-26 |
Masson Kristina EVP - Business Operations · Common Stock · 2026-05-21 | Other | — | — | 2026-05-21 | 2026-05-26 |
SEC filings
EDGAR filings in ACRV · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.